Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab

Coronavirus disease 2019 (COVID-19) can progress to cytokine storm that is associated with organ dysfunction and death. The purpose of the present study is to determine clinical characteristics associated with 28 day in-hospital survival in patients with coronavirus disease 2019 (COVID-19) that rece...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Autoimmun
Autori principali: Morrison, Austin R., Johnson, Joseph M., Griebe, Kristin M., Jones, Mathew C., Stine, John J., Hencken, Laura N., To, Long, Bianchini, Monica L., Vahia, Amit T., Swiderek, Jennifer, Ramesh, Mayur S., Peters, Michael A., Smith, Zachary R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier Ltd. 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7332925/
https://ncbi.nlm.nih.gov/pubmed/32646770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaut.2020.102512
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi